Ideal Option is a health care company based in Kennewick, Washington, that has been delivering personalized medicine to over 20,000 patients since its founding in 2006. With a network of 60 urban and rural office-based opioid treatment (OBOT) clinics across 10 states, Ideal Option focuses on tailored treatment programs that include MAT and behavioral counseling services to achieve superior outcomes. The company's emphasis on integrity and empathy is reflected in its commitment to delivering excellent patient care. Ideal Option extensively utilizes telemedicine technology to reach secondary and tertiary markets where access to treatment is limited or non-existent.
The company received a Private Equity Round investment on 06 February 2019 from The Blue Venture Fund. This investment underscores the confidence of experienced investors in Ideal Option's mission and approach. With its patient-centric model and innovative use of telemedicine technology, Ideal Option is well-positioned to continue its growth and expand its impact on improving access to personalized healthcare across the United States.
